CBAY - Cymabay Therapeu - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CBAY is currently covered by 11 analysts with an average price target of $35.9. This is a potential upside of $3.42 (10.53%) from yesterday's end of day stock price of $32.48.

Cymabay Therapeu's activity chart (see below) currently has 96 price targets and 114 ratings on display. The stock rating distribution of CBAY is 77.78% BUY and 22.22% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 80.16% with an average time for these price targets to be met of 496.81 days.

Highest price target for CBAY is $32.5, Lowest price target is $15, average price target is $35.9.

Most recent stock forecast was given by ED ARCE from HC WAINWRIGHT on 29-Feb-2024.

Currently out of the existing stock ratings of CBAY, 35 are a BUY (77.78%), 10 are a HOLD (22.22%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

32.5

$0.02 (0.06%)

2 months 27 days ago

17/18 (94.44%)

$0.31 (0.96%)

627

Hold

32.5

$0.02 (0.06%)

12

3 months 6 days ago

2/3 (66.67%)

$0.3 (0.93%)

129

Hold

32.5

$0.02 (0.06%)

33

3 months 12 days ago

14/16 (87.5%)

$0.32 (0.99%)

845

Hold

32.5

$0.02 (0.06%)

25

3 months 12 days ago

8/9 (88.89%)

$0.32 (0.99%)

891

Hold

32.5

$0.02 (0.06%)

34

3 months 13 days ago

9/12 (75%)

$0.38 (1.18%)

1210

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CBAY (Cymabay Therapeu) average time for price targets to be met?

On average it took 496.81 days on average for the stock forecasts to be realized with a an average price target met ratio 80.16

Which analyst has the current highest performing score on CBAY (Cymabay Therapeu) with a proven track record?

ELIANA MERLE

Which analyst has the most public recommendations on CBAY (Cymabay Therapeu)?

Eliana Merle works at UBS and has 4 price targets and 3 ratings on CBAY

Which analyst is the currently most bullish on CBAY (Cymabay Therapeu)?

Kristen Kluska with highest potential upside - $0.02

Which analyst is the currently most reserved on CBAY (Cymabay Therapeu)?

Joel Beatty with lowest potential downside - -$22.48

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?